Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.44 +0.08 (+21.56%)
As of: Oct 21, 2026 · 3:59 PM EDT

Karyopharm Therapeutics (KPTI) Other financing activities (2014 - 2025)

Updated

Karyopharm Therapeutics' Other financing activities was $2.59 million in FY2024.

Analysis

Karyopharm Therapeutics (KPTI) Other financing activities (2014 - 2025) Analysis & Trends

  • The FY2024 figure marks the lowest annual Other financing activities since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Karyopharm Therapeutics 12.16 Mn -214.27 Mn 32.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.46 Mn
Sep 30, 2014 562,000.00
API Access

Karyopharm Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KPTI&period=max&api_key=YOUR_API_KEY